In humans, CD36 expression correlates with triglyceride accumulation in NAFLD [13] and shows a notable increase in the liver of animal models of obesity and type 2 diabetes mellitus [14]. The gene discussed is CD36; the disease is metabolic dysfunction-associated steatotic liver disease.